Published 20 October 2026 · Reviewed by Dr Sin Yong
Ellansé cost is set by the formulation chosen, the number of syringes the anatomy calls for, the areas planned, whether placement is staged with review once the gel carrier has gone, and whether earlier filler must be mapped first. Singapore's rules restrict how fees may be advertised, so no figure appears here; Dr Sin Yong gives a written, itemised quote after examining you on Orchard Road.
Ellansé cost factors start with a choice that is easy to overlook: the formulation, since the versions differ in how slowly the microspheres resorb. Syringes are dosed for the collagen that follows rather than the gel seen at first, across areas such as the chin, jawline, temples and lateral cheek. Lips and tear troughs never appear on an Ellansé quote, and nothing is quoted from a photograph.
Why is there no Ellansé figure on this page?
Singapore's rules for medical advertising restrict how doctors may publish fees, and with Ellansé a number given before examination would be doubly misleading. The product is polycaprolactone microspheres in a gel carrier: the gel gives correction on the day and is absorbed, and the collagen the skin builds around the microspheres is what remains. Neither part can be dissolved. The amount a chin or a jawline calls for is dosed for that later collagen, not for how the gel looks in the mirror, and that is a judgement made on the face rather than from a menu. The practice-wide rules are on how fees are quoted.
Illustrative image — not a patient.
Does the Ellansé formulation change the fee?
Ellansé is supplied in more than one formulation, sharing the same microspheres and carrier but differing in how slowly the microspheres resorb, and therefore how long the collagen scaffold persists. The choice is made per patient and per area rather than for the whole face: Dr Sin Yong uses the firmer, longer-lasting formulation sparingly and in stages where definition is the goal, and where the goal is diffuse support under thinner skin he may choose the softer formulation or a different product altogether.
That choice carries a trade-off worth stating in words. Longer-lasting support also means a longer wait if the result is not what was wanted, because nothing in the syringe can be dissolved. The formulation is written into the plan with its reason, and the quote names it; a quote that does not say which formulation, or why, is leaving out the decision that matters most.
“Ellansé is dosed for the collagen that follows, not the gel you see on the day. A quote that fills to the mirror is a quote for a heavier face later.”
Dr Sin YongOn how Ellansé is quoted
How does the syringe logic work, and which areas are planned?
The product is supplied by the syringe, and the fee follows the number of syringes the plan calls for, which comes from the areas planned and the structural deficit in each. Ellansé suits firm tissue with good cover: a chin that needs projection, a jawline that needs a cleaner line, temples and lateral cheeks that have hollowed, and the backs of the hands where tendons have become visible. It is not placed in the lips, the tear troughs or thin, mobile skin, so those areas never appear on an Ellansé quote.
Illustrative image — not a patient.
Each area is read as a structure, not a surface. Placement is deep, on bone or in the deep fat where the anatomy allows, so the quantity is set by what the bone and deep fat need rather than by how much gel would look full on the day. Filling to a pleasing day-one result is how a lower face becomes heavier than intended later, so the plan is dosed for the collagen it will produce.
Area on the plan
What is being bought
What moves the quantity
Chin
Projection on bone
The degree of recession and the width of the chin
Jawline
A cleaner line from chin to angle
Length of the line and how much of it has softened
Temples and lateral cheek
Support for the lower face
Depth of hollowing and skin thickness over it
Lips, tear troughs
Not planned with Ellansé
A hyaluronic acid filler is assessed instead
What do staging, review visits and earlier filler add?
Because the gel is absorbed and the collagen then forms, the first point at which the real result can be judged is after the gel has gone. Dr Sin Yong under-treats at the first visit and reviews at that point; any further placement is decided then, so the review is part of the plan and appears on the quote. Staging can mean fewer syringes across the plan than a course fixed in advance would assume, and never more than the review supports.
Earlier filler is the other line. Ellansé is never placed over previous filler that has not been mapped, so where the face has had injectables before, an ultrasound scan comes first and is itemised; dissolving earlier hyaluronic acid filler is a separate step, and a non-dissolvable product already in place may change the plan or rule Ellansé out. Lumps from earlier biostimulator are assessed under filler correction, and the distinction between an Ellansé nodule and migrated Sculptra is under Ellansé nodules vs Sculptra migration. The consultation is a medical visit with its own fee, and physician time runs through every line because Dr Sin Yong places the product himself.
What is not on the quote, and how should you compare it?
Not on the quote: packages sold on the day, incentives for reviews, and any treatment the assessment does not support. The consultation can end with the advice that a reversible hyaluronic acid filler is the more forgiving place to start, or that a jowl is a laxity problem for VF Lift – Vertical Facelift rather than a volume problem, since adding volume below a descended jowl makes it heavier.
When comparing with a quote from elsewhere, look for the formulation named with its reason, the areas with the quantity for each, whether earlier filler is scanned, who performs the injection, and whether a review after the gel has gone is included. A lower figure that omits any of these is describing a different treatment. How Ellansé compares with Sculptra and Radiesse is on the collagen biostimulators guide.
Your next step
1. MessageWhatsApp +65 8023 7170 with what is bothering you. A reply comes from the clinic, not a bot.
2. AssessmentDr Sin Yong examines you himself on Orchard Road, with ultrasound where earlier filler is involved.
3. A plan in writingWhat he would do, what he would not, the fee factors, and the option of no treatment.
Every treatment is performed by Dr Sin Yong personally. Singapore Medical Council registered · invited to share his clinical expertise internationally for CLASSYS, DEKA, Fotona, Hironic and Ilooda.
Bring the product name and date of any earlier filler; the scan comes before any Ellansé plan. How consultations work.
Singapore's rules restrict how fees may be advertised, so no figure is given here. The fee follows the formulation chosen, the number of syringes the areas call for, whether placement is staged with review once the gel has gone, and whether earlier filler must be scanned or dissolved first. A written, itemised quote follows examination by Dr Sin Yong.
The formulation is one of the factors, and the quote names which is proposed and why. The longer-lasting formulation also means a longer wait if the result is not what was wanted, because polycaprolactone cannot be dissolved, so it is chosen per area for a structural reason rather than as an upgrade.
There is no fixed number. The quantity follows the areas planned, such as chin, jawline, temples or hands, and the structural deficit found in each, dosed for the collagen that forms rather than for the gel seen on the day. Dr Sin Yong under-treats at the first visit and decides any further placement at review.
They are different products with different planning. Ellansé is dosed for collagen, placed deep in firm tissue, staged, and cannot be dissolved, so it carries a scan of earlier filler and a review after the gel has gone. A hyaluronic acid filler gives its volume on the day and can be reversed, which is why it is often the more forgiving first injectable.
References
Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé). Clinical, Cosmetic and Investigational Dermatology (de Melo F et al.), 2017. source
Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler. Journal of Cosmetic and Laser Therapy (Kim JA, Van Abel D), 2015. source
Dermal Fillers (Soft Tissue Fillers). U.S. Food and Drug Administration, 2023. source
About this page: written and medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last reviewed 20 October 2026 · Illustrative images only, not patients · Editorial policy
